Crisis in Cancer Treatment: The Dark Side of Keytruda's High Cost

A significant crisis is unfolding in India surrounding Keytruda, a vital cancer drug, as high costs have led to a dangerous black market. Investigations reveal a network of counterfeiters exploiting desperate patients, with alarming cases of fake medications causing harm. As the demand for effective cancer treatments rises, the need for vigilance and regulatory oversight becomes critical. This article delves into the complexities of the situation, highlighting the risks posed by counterfeit drugs and the importance of purchasing medications through verified channels.

By Narendra Chaudhary Apr 13, 2026, 17:38 IST

The Alarming Situation Surrounding Keytruda

A groundbreaking cancer medication, often hailed as a 'miracle' in the field of oncology, is currently embroiled in a troubling crisis in India, intertwining medical advancements with criminal activities. Central to this issue is Keytruda (pembrolizumab), a cutting-edge immunotherapy that has significantly improved treatment outcomes for various aggressive cancers, including lung, cervical, and melanoma. However, the high cost of this drug is staggering, with each 100 mg vial priced at over ₹1.5 lakh, leading to monthly treatment costs exceeding ₹3 lakh for many patients. This exorbitant pricing has inadvertently fostered a perilous black market that exploits the desperation of patients.

An investigation has unveiled a sophisticated network involving pharmacists, intermediaries, and potential connections within hospital systems. Authentic drugs are reportedly being diverted from leading hospitals and funneled back into illegal supply chains. The alarming aspect of this operation is its complexity: counterfeiters are said to reuse original packaging, replicate batch numbers, and refill used vials, making fake medications nearly indistinguishable from the real ones. In one distressing incident, a cancer patient's family spent nearly ₹16 lakh on what they thought were discounted vials of the drug, only to find out later that the injections contained antifungal medication instead of the intended cancer treatment. By that time, the financial and medical repercussions had already taken their toll.

Widespread Interstate Drug Trafficking

Interstate Drug Rackets

This issue is not confined to a single location. Investigations across various states have revealed interstate drug trafficking operations dealing in high-value oncology medications, often utilizing fake invoices, shell companies, and improper storage methods that further compromise drug efficacy. In some instances, drugs labeled 'Not for Sale' and meant for government distribution have been repackaged and sold at full price in the open market. From a healthcare standpoint, the implications are dire. Unlike conventional medications, immunotherapy drugs like Keytruda function by stimulating the body’s immune system to combat cancer cells. The use of counterfeit versions not only wastes valuable treatment time but may also lead to disease progression without patients realizing that the therapy is ineffective.

Experts attribute the underlying causes of this crisis to a combination of exorbitant drug prices, limited access, and deficiencies in supply chain oversight. With India's cancer burden rapidly increasing and expected to rise significantly in the coming years, the demand for such therapies is intensifying. Law enforcement agencies have started to take action, with numerous arrests and seizures reported in recent months. However, the magnitude of the issue indicates a deeply rooted network that necessitates enhanced regulatory oversight, improved hospital inventory management, and stricter penalties for violators.

Protecting Patients and Families

For Loved Ones

For patients and their families, the message is clear: vigilance is essential in the quest for life-saving treatments. Acquiring medications solely through verified hospital channels and steering clear of 'discounted' offers outside authorized systems can be the key to receiving effective care rather than falling victim to a dangerous scam. In a landscape where hope already comes at a steep price, the rise of counterfeit cancer drugs transforms that hope into a potentially lethal gamble.